No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Chronic Lymphocytic Leukemia (CLL) therapy with Ibrutinib and Venetoclax guided by measurable residual disease improves progression-free survival

byMinjee Kim

January 31, 2024

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in NEJM.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

World Health Organization warns that one in six infections now antibiotic resistant

Increasing cancer incidence rates in younger and older adults worldwide

Punjab launches AI screening program this week

#VisualAbstract: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure

RelatedReports

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

The Scan by 2 Minute Medicine®

World Health Organization warns that one in six infections now antibiotic resistant

October 23, 2025

Population-based risk factors and geographical trends identified for vitiligo

Oncology

Increasing cancer incidence rates in younger and older adults worldwide

October 20, 2025

Blindness and visual impairment decreasing worldwide

AI Roundup

Punjab launches AI screening program this week

September 30, 2025

AI Roundup

2MM: AI Roundup –Lilly launches TuneLab AI drug discovery, smart wound healing bandage, and Punjab cancer screening [September 25th, 2025]

September 28, 2025

Lariat device for left atrial appendage exclusion associated with adverse events

Apixaban lowers the risk of stroke in subclinical atrial fibrillation

Cervical cancer screening practices less cost-effective than suggested guidelines

Atezolizumab in addition to bevacizumab and platinum-based chemotherapy improves survival in metastatic cervical cancer

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

Worse breast cancer death rates for non-screen detected ductal carcinoma situ

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result